Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)

被引：0
|
作者：
Carlton, H. C. [1 ]
Banerjee, A. [2 ]
Burnett, D. [3 ]
Shipman, K. E. [4 ]
机构：
[1] Univ Hosp Sussex NHS Trust, Dept Clin Chem, Chichester, England
[2] Univ Hosp Sussex NHS Trust, Dept Cardiol, Chichester, England
[3] Worthing Dist Hosp, Dept Cardiol, Worthing, England
[4] Brighton & Sussex Med Sch, Dept Med Educ, Brighton, England
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2709
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
    Collins, Dylan R. J.
    Tompson, Alice C.
    Onakpoya, Igho J.
    Roberts, Nia
    Ward, Alison M.
    Heneghan, Carl J.
    BMJ OPEN, 2017, 7 (03):
  • [22] Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
    Robson, J.
    HEART, 2008, 94 (10) : 1331 - 1332
  • [23] Multiple biomarker assessment in primary prevention of cardiovascular disease
    Daniels L.B.
    Current Cardiovascular Risk Reports, 2009, 3 (2) : 131 - 136
  • [24] THE BIOIMAGE STUDY: NOVEL APPROACHES TO RISK ASSESSMENT IN THE PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Muntendam, P.
    Gardiner, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [25] Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews
    Krzysztof Studziński
    Tomasz Tomasik
    Janusz Krzysztoń
    Jacek Jóźwiak
    Adam Windak
    BMC Cardiovascular Disorders, 19
  • [26] Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews
    Studzinski, Krzysztof
    Tomasik, Tomasz
    Krzyszton, Janusz
    Jozwiak, Jacek
    Windak, Adam
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (1)
  • [27] Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: Implications in cardiovascular risk factors management and primary prevention of cardiovascular disease
    Torres, Tiago
    Sales, Rita
    Vasconcelos, Carlos
    da Silva, Berta Martins
    Selores, Manuela
    JOURNAL OF DERMATOLOGY, 2013, 40 (11): : 923 - 926
  • [28] Should we Consider Lipoprotein (a) in Cardiovascular Disease Risk Assessment in Patients with Familial Hypercholesterolaemia?
    Anagnostis, Panagiotis
    Siolos, Pavlos
    Krikidis, Dimitrios
    Goulis, Dimitrios G.
    Stevenson, John C.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (31) : 3665 - 3671
  • [29] Physicians' attitudes towards cardiovascular guidelines and risk assessment tools: relation with the management of risk factors in the primary prevention setting
    Dallongeville, J.
    Banegas, J. R.
    Halcox, J.
    Guallar, E.
    Borghi, C.
    De Backer, G.
    Tubach, F.
    Perk, J.
    Steg, P. G.
    Rodriguez Artalejo, F.
    EUROPEAN HEART JOURNAL, 2011, 32 : 973 - 973
  • [30] Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease
    Panza, Gregory A.
    Blazek, Olivia
    Tortora, Joseph
    Saucier, Stephanie
    Fernandez, Antonio B.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (06) : 748 - 755
12345